DOI: 10.1002/anie.201105795
Heterocycle Synthesis
An Alkyne Hydroacylation Route to Highly Substituted Furans**
Philip Lenden, David A. Entwistle, and Michael C. Willis*
Heterocyclic compounds, such as the bioactive natural
products pukalide and nakadomarin A, and the hugely
successful drug molecules ranitidine (Zantac) and atorvasta-
tin (Lipitor) are of great importance in pharmaceutical,
agrochemical, and other fine-chemical applications
(Scheme 1).[1] While there exists a range of methods for
catalyst systems, and generate no by-products because of their
100% atom-economy.[3–5] In addition, a broad range of
aldehydes can now be employed, and particularly in the
case of alkyne hydroacylation, significant substitution of the
unsaturated component can be tolerated, thus allowing for
the regioselective production of highly substituted complex
molecules in one catalytic intermolecular carbon–carbon
bond forming step. Herein, we demonstrate the utility of
intermolecular alkyne hydroacylation in the efficient syn-
thesis of di- and trisubstituted furans and related heterocycles.
g-Hydroxy-a,b-enones are known to undergo acid-cata-
lyzed dehydrative cyclization to form furans, and this trans-
formation has been exploited by several research groups,[6]
most notably in the recent work from Donohoe et al.[7] The
intermolecular hydroacylation of an aldehyde with readily
available propargylic alcohols would permit the synthesis of
g-hydroxy-a,b-enones with 100% atom efficiency; coupling
this carbon–carbon bond formation with an acid-catalyzed
dehydrative cyclization would allow for the regioselective
synthesis of di- or trisubstituted furans. The associated
disconnection is novel for this type of heterocycle (Scheme 2).
Our initial investigations to realize the above route to
furans focused on the combination of propargyl alcohol 1a
Scheme 1. Examples of significant heterocycle-containing natural prod-
ucts and pharmaceuticals.
transforming relatively complex starting materials into sub-
stituted heterocycles, and for the functionalization of existing
heterocycles, there is less precedent for methodology which
involves the direct, regiodefined synthesis of highly substi-
tuted heterocycles from simple starting materials.[2] As such,
new methods for the synthesis of substituted heterocycles (or
their precursors) are potentially of significant value. This is
particularly true if such methods do not suffer from the same
drawbacks as the traditional syntheses of 1,4-dicarbonyl
compounds, the classic substrates for the preparation of
furans, thiophenes, and pyrroles; these syntheses are often
either step- or atom-inefficient. The recent advances achieved
in intermolecular alkene and alkyne hydroacylation chemis-
try means that these transformations are now ideal methods
to exploit for the synthesis of heterocyclic molecules, because
they employ simple substrates and commercially available
Scheme 2. An alkyne hydroacylation route to furans.
and the S-chelating alkyl aldehyde 2a (Table 1). The hydro-
acylative union of these two substrates using a dppe-derived
Rh catalyst proceeded without incident. However, attempts
to achieve a dehydrative cyclization using TFA provided only
a small amount of the desired furan 3a (entry 1). Reducing
the time for the cyclization event to 1 hour, and then to
10 minutes, increased the yield of furan up to 50% (entries 2
and 3). After exploring the use of several alternative acids, it
was found that the use of p-TSA increased the yield to 66%
(entries 4–7). Given the known acid sensitivity of simple
alkyl-substituted furans we speculated that the purification of
the furan product by chromatography on silica gel might be
responsible for the moderate yields of the isolated products.[8]
Accordingly, although the use of neutral alumina offered no
advantage, purifications employing Florisil (magnesium sili-
cate) or triethylamine-doped silica allowed the furan to be
isolated in significantly increased yields (entries 8–10).
[*] P. Lenden, Dr. M. C. Willis
Department of Chemistry, University of Oxford
Chemistry Research Laboratory
Mansfield Road, Oxford, OX1 3TA (UK)
E-mail: michael.willis@chem.ox.ac.uk
Dr. D. A. Entwistle
Research API, Pfizer Global Research and Development
Sandwich, Kent, CT13 9NJ (UK)
With the optimized conditions established, a short series
of 2,5-disubstituted furans was prepared (Scheme 3). Prop-
argylic aryl and heteroaryl substituents could be introduced
[**] This work was supported by the EPSRC and Pfizer.
Supporting information for this article is available on the WWW
Angew. Chem. Int. Ed. 2011, 50, 10657 –10660
ꢀ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
10657